Sign inJoin waitlistJoin the waitlist

LS

Lasika Seneviratne

Clinical Instructor/Research Associate · University of Southern California/Los Angeles General Medical Center

Credentials: · · · ·

History

University of Southern California/Los Angeles General Medical Center
Present

University of Southern California
1999–2001
Hematology and Medical Oncology
University of Southern California/Los Angeles General Medical Center
1996–1999
Internal Medicine
University of Southern California/Los Angeles General Medical Center
1993–1996
General Hospital
1992–1993
Doctor of Medicine
1988–1992

Research

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm,…
The Lancet Oncology · 2017 · 173 citations
Evolving characteristics of AIDS-related lymphoma
Blood · 2000 · 110 citations
Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)
Journal of Thoracic Oncology · 2021 · 48 citations

Bharat Nathwani
3 papers
AL
Alexandra Levine
2 papers
AT
Anil Tulpule
2 papers
Bruno Fang
2 papers
DV
Daniel Vaena
2 papers
DD
Davey Daniel
2 papers
Dennis Slater
2 papers
HS
Harry Staszewski
2 papers
BC
Bo Chao
1 paper
CN
Chaitali Nangia
1 paper
DB
David Berz
1 paper
DS
David Spigel
1 paper

Clinical trials

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Principal investigator · Recruiting · Phase 1, Phase 2
AVM Biotechnology Inc
2020–2028
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Aminex Therapeutics, Inc.
2026–2028
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2024–2030
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Site PI · Recruiting · Phase 3
BriaCell Therapeutics Corporation
2023–2028